Crinetics Pharmaceuticals Inc
CRNX
$84.95+0.00%
End of day · as of Oct 9, 2026, 7:15 AM ET
Mkt cap
$2.76B
EV/Sales
345.2
P/E ratio
N/A
FY2025 Revenue
$7.70M
EPS (TTM)
$-5.05
Gross Margin (FY2025)
86.02%
Profit Margin (FY2025)
-6046.22%
Beta
0.28
Div yield
N/A
Sector
Healthcare
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. Revenue was up 640.7% from 2024-12-31 to 2025-12-31. CRNX currently screens at market cap $2.76B.
Use this CRNX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CRNX income, balance, and cash tables.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company in the Healthcare sector.
Latest cached Crinetics Pharmaceuticals Inc (CRNX) revenue for Dec 31, 2025 was $7.7M. Net income was -$465.3M. Statements: https://lician.com/financials/crnx
Crinetics Pharmaceuticals Inc (CRNX) market capitalization is $2.76B on the latest cached snapshot.
Crinetics Pharmaceuticals Inc (CRNX) cached previous close $84.95; day range $84.92 – $85.01; volume 8,182,078. Session quote: https://lician.com/quote/crnx
Crinetics Pharmaceuticals Inc (CRNX) latest cached earnings event is "CRNX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CRNX filing is 8-K · Sep 1, 2026. Filings: https://lician.com/sec/crnx